Showing results (191-200 of 618) with videos related to
Sort By:
Pageof 62
Neuro-Oncology|May 24, 2012
Current clinical development of PI3K pathway inhibitors in glioblastomaPatrick Y Wen, Eudocia Q Lee, David A Reardon, et al.Nature Reviews. Disease Primers|May 9, 2024
GliomaMichael Weller, Patrick Y Wen, Susan M Chang, et al.Neuro-Oncology|June 9, 2021
The use of external control data for predictions and futility interim analyses in clinical trialsSteffen Ventz, Leah Comment, Bill Louv, et al.Journal of Neuro-Oncology|August 27, 2013
Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survivalChristina Chen, Raymond Huang, Ainsley MacLean, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical TrialsRifaquat Rahman, Steffen Ventz, Robert Redd, et al.Nature Clinical Practice. Oncology|July 31, 2008
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNSF Stephen Hodi, Darryl A Oble, Jan Drappatz, et al.Journal of Neuro-Oncology|May 28, 2017
Neuro-oncology family caregivers' view on keeping track of care issues using eHealth systems: it's a question of timeFlorien W Boele, Cornelia F van Uden-Kraan, Karen Hilverda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2012
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03Eudocia Q Lee, Vinay K Puduvalli, Joel M Reid, et al.Cancer Nursing|October 5, 2021
The Added Value of Family Caregivers' Level of Mastery in Predicting Survival of Glioblastoma Patients: A Validation StudyFlorien W Boele, Jason Weimer, Amir H Zamanipoor Najafabadi, et al.Neuro-Oncology Practice|August 7, 2019
Response Assessment in Neuro-Oncology (RANO): more than imaging criteria for malignant gliomaSusan M Chang, Patrick Y Wen, Michael A Vogelbaum, et al.Pageof 62